A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/00 (2006.01) A61K 31/196 (2006.01) A61K 31/573 (2006.01) A61K 31/675 (2006.01) A61K 31/7076 (2006.01) A61K 38/19 (2006.01) A61K 38/20 (2006.01) A61K 38/21 (2006.01) A61K 39/395 (2006.01) C07K 16/28 (2006.01)
Patent
CA 2350058
A method of treating hematologic malignancies associated with a high number of circulating tumor cells by the administration of a therapeutic chimeric anti- CD20 antibody. These malignancies include in particular B-prolymphocytic leukemia (B-PLL), chronic lymphocytic leukemia (CLL), and transformed non- Hodgkin's lymphoma.
L'invention concerne une méthode de traitement d'affections malignes hématologiques associées à un nombre élevé de cellules tumorales en circulation. Cette méthode consiste à administrer un anticorps chimère anti-CD 20 thérapeutique. Lesdites affections malignes comprennent notamment la leucémie prolymphocytaire B (B-PLL), leucémie prolymphocytaire chronique (CLL) ainsi que le lymphome non hodgkinien transformé.
Grillo-Lopez Antonio J.
White Christine A.
Biogen Idec Inc.
Gowling Lafleur Henderson Llp
Idec Pharmaceuticals Corporation
LandOfFree
Treatment of hematologic malignancies associated with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of hematologic malignancies associated with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hematologic malignancies associated with... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1481852